Conjoint Analysis of Patient Preferences in Joint Interventions

Overview

This study is an observational study to test and validate a questionnaire and statistical model used to determine patient preferences regarding treatment for any one of 11 musculoskeletal conditions: hip arthritis, knee arthritis, hip labral tears and femoroacetabular impingement (FAI), osteochondritis dissecans, Achilles tendon rupture, patellofemoral dislocation, distal radius fracture, and fractures of the hip, ankle, tibia, and proximal humerus. This study aims to understand how multiple treatment variables, including pain, rehabilitation time, cost, and choice of surgical versus non-surgical intervention, impact patients' decision-making processes and ultimate choice of treatment.

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Health Services Research
    • Masking: None (Open Label)
  • Study Primary Completion Date: July 2024

Interventions

  • Other: Decision tool
    • A survey will be created for each condition that reflects the most important aspects of the corresponding treatment process.
  • Other: Standard treatment information
    • Participants will receive information pertaining to one of the 12 specified musculoskeletal conditions. This information will reflect information commonly distributed to patients seeking to make a decision concerning treatment for their condition.

Arms, Groups and Cohorts

  • Experimental: Decision tool
    • A “decision tool” will be provided to participants who currently or previously have had one of the following 12 musculoskeletal conditions: hip arthritis, knee arthritis, ankle arthritis, hip labral tears and femoroacetabular impingement (FAI), osteochondritis dissecans, Achilles tendon rupture, patellofemoral dislocation, distal radius fracture, and fractures of the hip, ankle, tibia, and proximal humerus.
  • Active Comparator: Standard treatment information
    • “Standard treatment information” will be provided to participants who currently or previously have had one of the following 12 musculoskeletal conditions: hip arthritis, knee arthritis, ankle arthritis, hip labral tears and femoroacetabular impingement (FAI), osteochondritis dissecans, Achilles tendon rupture, patellofemoral dislocation, distal radius fracture, and fractures of the hip, ankle, tibia, and proximal humerus.

Clinical Trial Outcome Measures

Primary Measures

  • Patient preferences survey – Hip Arthritis
    • Time Frame: 3-5 years
    • Patient-voiced preferences regarding treatment for hip arthritis based on questionnaires
  • Patient preferences survey – Knee Arthritis
    • Time Frame: 2 years
    • Patient-voiced preferences regarding treatment for knee arthritis based on questionnaires
  • Patient preferences survey – hip labral tears and FAI
    • Time Frame: 3-5 years
    • Patient-voiced preferences regarding treatment for hip labral tears and femoroacetabular impingement (FAI) based on questionnaires
  • Patient preferences survey – Osteochondritis dissecans
    • Time Frame: 3-5 years
    • Patient-voiced preferences regarding treatment for osteochondritis dissecans based on questionnaires
  • Patient preferences survey – Achilles tendon rupture
    • Time Frame: 2 years
    • Patient-voiced preferences regarding treatment for Achilles tendon rupture based on questionnaires
  • Patient preferences survey – patellofemoral dislocation
    • Time Frame: 2 years
    • Patient-voiced preferences regarding treatment for patellofemoral dislocation based on questionnaires
  • Patient preferences survey – distal radius fracture
    • Time Frame: 3-5 years
    • Patient-voiced preferences regarding treatment for distal radius fracture based on questionnaires
  • Patient preferences survey – hip fracture
    • Time Frame: 3-5 years
    • Patient-voiced preferences regarding treatment for hip fracture based on questionnaires
  • Patient preferences survey – ankle fracture
    • Time Frame: 3-5 years
    • Patient-voiced preferences regarding treatment for ankle fracture based on questionnaires
  • Patient preferences survey – tibia fracture
    • Time Frame: 3-5 years
    • Patient-voiced preferences regarding treatment for tibia fracture based on questionnaires
  • Patient preferences survey – proximal humerus fracture
    • Time Frame: 3-5 years
    • Patient-voiced preferences regarding treatment for proximal humerus fracture based on questionnaires
  • Patient preferences survey – Ankle Arthritis
    • Time Frame: 3-5 years
    • Patient-voiced preferences regarding treatment for ankle arthritis based on questionnaires

Participating in This Clinical Trial

Inclusion Criteria

  • Patient age criteria for each condition is listed below: 1. Hip arthritis: 50-80 years 2. Knee arthritis: 50-80 years 3. Hip labral tears and FAI: 18-65 4. Osteochondritis dissecans: parents with children between the ages of 8-18 5. Achilles tendon rupture: 25-60 years 6. Patellofemoral dislocation: parents with children between the ages of 8-18 and adults between 18-50 years of age 7. Distal radius fracture: 18-80 years 8. Hip fracture: 50-85 years 9. Ankle fracture: 18-80 years 10. Tibia fracture: 18-80 years 11. Proximal humerus fracture: 18-80 years 12. Ankle Arthritis: 40-80 years Exclusion Criteria:

  • Inability to read, understand and give effective English consent

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: 85 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Duke University
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Richard C. Mather III, MD, MBA, Principal Investigator, Duke University

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.